Redeye: Alligator Bioscience (Q3 Review) - Rights Issue of up to SEK120m
Refinitivน้อยกว่า 1 นาทีในการอ่าน
Redeye reviews Alligator Bioscience’s Q3 report 2025. The main event is the rights issue of SEK120m announced on Wednesday evening. The main positive event was the extensive investigator-sponsored study in bile duct cancer in France.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
เข้าสู่ระบบหรือสร้างบัญชีฟรีถาวรเพื่ออ่านข่าวนี้